5.69 USD
▲+0.25+9.42%
盘后 5.50 0.00%
2026-08-03
市值
$5.92M
市盈率
—
EPS
-0.08
股息率
—
52 周区间
5.04 – 12.05
成交量
2.58K
Beta
1.99
目标价
—
52W 低 5.0452W 高 12.05
价格走势
公司简介
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson’s disease levodopa-induced dyskinesia. The company also develops ADX71149, which is in phase 1 for undisclosed indication; and GABAB PAM for the treatment pain, anxiety, ad...